Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-02

Clinical Trial Update: Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating the safety and efficacy of boric acid vaginal inserts for vulvovaginal candidiasis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Boric acid vaginal inserts (boric acid)

Snippet

Sponsor: pH-D Feminine Health LLC | Conditions: Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital | Phase 3 | Status: RECRUITING